In a previous study by our team, CD4+ T cell depletion in a GBM mouse cohort resulted in lower mouse survival and lower efficacy of the oncolytic virus therapy,24 here correlated with gut dysbiosis. This evidence concerns the gene CD4 and glioblastoma.